retatrutide cagrilintide blend + – VAYN Reta/Cagri Blend – 12.5mg/2.5mg |

One hypoglycaemic event occurred in the placebo group

CONCLUSION GLP-1 receptor agonists offer a powerful tool for weight loss, with significant benefits for reducing OSA severity through reductions in airway-obstructing fat deposits and improved metabolic health

The GIP receptor activation provides complementary metabolic benefits, including improved insulin sensitivity and additional appetite suppression

CONVERT FAT TO ENERGY This formula contains conjugated linoleic acid (CLA) and carnitine, two popular ingredients that have been show to work synergistically to help the body convert fat cells into energy

Lipid peroxidation is another endogenous pathway that contributes to free radical formation

Community-reported research-peptide doses cluster around 100-300 mcg per dose (non-DAC, daily or twice-daily) or 1-2 mg per dose (DAC, 1-2x weekly)